Letko, Brosseau & Associates’s Medicenna Therapeutics Corp. Common Shares MDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-120,000
| Closed | -$35.4K | – | 100 |
|
|
2023
Q3 | $35.4K | Hold |
120,000
| – | – | ﹤0.01% | 97 |
|
|
2023
Q2 | $57.8K | Sell |
120,000
-50,000
| -29% | -$24.1K | ﹤0.01% | 93 |
|
|
2023
Q1 | $107K | Hold |
170,000
| – | – | ﹤0.01% | 87 |
|
|
2022
Q4 | $77.9K | Buy |
170,000
+70,000
| +70% | +$32.1K | ﹤0.01% | 96 |
|
|
2022
Q3 | $83K | Hold |
100,000
| – | – | ﹤0.01% | 98 |
|
|
2022
Q2 | $116K | Hold |
100,000
| – | – | ﹤0.01% | 96 |
|
|
2022
Q1 | $128K | Hold |
100,000
| – | – | ﹤0.01% | 99 |
|
|
2021
Q4 | $163K | Hold |
100,000
| – | – | ﹤0.01% | 105 |
|
|
2021
Q3 | $277K | Buy |
+100,000
| New | +$277K | ﹤0.01% | 100 |
|